Subscribe

Inspiration Healthcare Group plc (IHC.L)

GBp18.00 +0.50 (+2.86%)
GB LSE Healthcare Medical - Devices
Address Satellite Business Village RH10 9NE
Crawley, GB
CEO Harout Rafi Stepanian
Website inspiration-healthcare.com
IPO 2001-12-14
ISIN GB00BXDZL105

Explore sections of this company profile

Description

Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a strong focus on neonatal intensive care. This includes air/oxygen blenders; the Tecotherm Neo, a sophisticated servo-controlled device that precisely manages infant body temperature through continuous cooling and warming, making minute adjustments every two seconds to ensure stability; LifeStart, a bedside unit for neonatal resuscitation; and Inspire rPAP, a non-invasive, two-piece system crucial for the initial stabilization and resuscitation of infants. Beyond neonatal care, Inspiration Healthcare also supplies adult intensive care solutions, such as AlphaCore5, a patient warming system designed to prevent inadvertent hypothermia. For neonates, they provide CosyTherm2, another dedicated patient warming system for precise temperature management. Their offerings also encompass various respiratory disposables and thermoregulating products specifically for babies. In addition to its proprietary innovations, the company distributes third-party medical products, including infusion therapy items vital for parenteral feeding and chemotherapy. Inspiration Healthcare Group further enhances its services by offering technology support and supplying spare parts. Established in 1998, Inspiration Healthcare Group plc maintains its headquarters in Crawley, United Kingdom.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
GBp18.00 +0.50 (+2.86%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
83.4K
Beta
0.87
Float Shares
51.77M
Free Float %
57.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% -13.46% -22.68% -2.17% +47.54% +57.34% -7.02% -57.55% -82.76% -59.05% -97.45%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
18.00
Ratings Trend (MoM) 67% Bullish
Rating 2026-06 Change
Strong Buy 0 0
Buy 2 0
Hold 1 +1
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.40
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Devices: +11.2%
    +24.3% ★ Q1'26: +36.5% (vs Q1'24)
  • ✗
    EPS growth Medical - Devices: +28.5%
    +93.9% ★ Q1'26: +90.1% (vs Q1'24)
  • ✓
    FCF margin FCF growth · Medical - Devices: +30.9%
    +12.2% Q1'26: +13.2% (vs Q1'24)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    +1.1% Q1'26: -2.5% (vs Q1'24)
  • ✗
    ROIC Medical - Devices: +3.3%
    +2.0% Q1'26: -8.8% (vs Q1'24)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +12.7% Q1'26: +31.1% (vs Q1'24)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    4.97× Q1'26: 10.21× (vs Q1'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.87) × ERP
WACC = 64% × Ke + 36% × Kd (8.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 18.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Jan 2016
actual 		Jan 2017
actual 		Jan 2018
actual 		Jan 2019
actual 		Jan 2020
actual 		Jan 2021
actual 		Jan 2022
actual 		Jan 2023
actual 		Jan 2024
actual 		Jan 2025
actual 		Jan 2026
2 Rev. Ana.
1 EPS Ana. 		Jan 2027
2 Rev. Ana.
1 EPS Ana. 		Jan 2028
3 Rev. Ana.
2 EPS Ana. 		Jan 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
12.28M
est: 13.00M (-5.5%)
14.32M
est: 14.35M (-0.2%)
15.50M
est: 15.50M (0.0%)
15.49M
est: 15.48M (+0.0%)
17.78M
est: 17.80M (-0.1%)
36.98M
est: 36.51M (+1.3%)
41.05M
est: 41.01M (+0.1%)
41.23M
est: 41.07M (+0.4%)
37.63M
est: 37.03M (+1.6%)
38.25M
est: 38.30M (-0.1%)
47.50M
47.48M – 47.52M
+24.0% YoY
40.49M
40.47M – 40.52M
-14.8% YoY
36.55M
32.63M – 43.94M
-9.7% YoY
35.60M
35.59M – 35.61M
-2.6% YoY
EBITDA
644.0K
est: -134.5K (+578.9%)
652.0K
est: -148.4K (+539.4%)
1.43M
est: -160.3K (+994.6%)
1.58M
est: 1.43M (+10.6%)
1.76M
est: 1.83M (-3.3%)
4.48M
est: -377.6K (+1,285.1%)
6.17M
est: 3.72M (+66.0%)
2.76M
est: -424.8K (+748.7%)
-2.43M
est: -383.0K (-534.5%)
-12.44M
est: -941.3K (-1,221.9%)
-1.17M
-1.17M – -1.17M
-24.0% YoY
-995.2K
-995.8K – -994.5K
+14.8% YoY
-898.2K
-1.08M – -802.0K
+9.7% YoY
-874.9K
-875.3K – -874.6K
+2.6% YoY
EBIT
493.0K
est: -804.1K (+161.3%)
448.0K
est: -887.3K (+150.5%)
1.23M
est: -958.6K (+228.5%)
1.21M
est: 1.20M (+0.8%)
1.15M
est: 1.39M (-17.7%)
3.25M
est: -2.26M (+243.8%)
4.26M
est: 2.44M (+74.5%)
471.0K
est: -2.54M (+118.5%)
-4.87M
est: -2.29M (-112.5%)
-14.65M
est: -2.96M (-395.4%)
-3.67M
-3.67M – -3.67M
-24.0% YoY
-3.13M
-3.13M – -3.13M
+14.8% YoY
-2.82M
-3.39M – -2.52M
+9.7% YoY
-2.75M
-2.75M – -2.75M
+2.6% YoY
Net Income
12.0K
est: 2.07M (-99.4%)
312.0K
est: 2.46M (-87.3%)
1.22M
est: 2.30M (-46.9%)
1.10M
est: 1.22M (-9.8%)
733.0K
est: 1.27M (-42.1%)
2.82M
est: 4.61M (-39.0%)
4.23M
est: 1.57M (+169.0%)
272.0K
est: 556.7K (-51.1%)
-6.03M
est: -794.9K (-659.0%)
-14.97M
est: -2.58M (-479.1%)
142.5K
89.6K – 195.3K
+105.5% YoY
-732.3K
-852.7K – -611.8K
-614.0% YoY
-838.4K
-1.74M – 59.9K
-14.5% YoY
-1.56M
-1.76M – -1.46M
-86.1% YoY
SGA
5.02M
est: 3.46M (+45.3%)
3.64M
est: 3.81M (-4.7%)
3.79M
est: 4.12M (-8.0%)
5.70M
est: 4.12M (+38.3%)
6.51M
est: 4.73M (+37.5%)
12.37M
est: 10.41M (+18.9%)
15.13M
est: 14.18M (+6.7%)
16.02M
est: 10.92M (+46.8%)
4.24M
est: 9.84M (-56.9%)
4.78M
est: 10.77M (-55.6%)
13.36M
13.35M – 13.36M
+24.0% YoY
11.39M
11.38M – 11.39M
-14.8% YoY
10.28M
9.18M – 12.35M
-9.7% YoY
10.01M
10.01M – 10.01M
-2.6% YoY
EPS
0.00
est: 0.03 (-98.5%)
0.01
est: 0.03 (-67.1%)
0.04
est: 0.03 (+37.7%)
0.04
est: 0.03 (+7.3%)
0.02
est: 0.04 (-44.3%)
0.05
est: 0.06 (-12.1%)
0.06
est: 0.05 (+29.6%)
0.00
est: 0.01 (-42.9%)
-0.09
est: -0.01 (-785.4%)
-0.19
est: -0.03 (-578.6%)
0.00
0.00 – 0.00
+105.7% YoY
-0.01
-0.01 – -0.01
-614.2% YoY
-0.01
-0.02 – 0.00
-33.6% YoY
-0.02
-0.02 – -0.02
-59.3% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-10 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-09 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-03 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-02 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-06-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-26 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-19 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-18 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
5.44M
OE per share TTM
0.05
Owner's Yield
25.91%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
23.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
2.3K
Shares Outstanding
89.66M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Harout Rafi Stepanian Chief Executive Officer & Director 295.5K male
Alan Musgrave Olby Chief Financial Officer & Director 236.0K male
Charles Eugene Shackleton Strickland Company Secretary — —
Laura Edwards Group Head of Marketing — —
Nigel Weston Head of Operations — —
Peter Reynolds Group Vice President of Clinical, Research, Innovation & Compliance — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices